Monday, May 29, 2017

Frequently Asked Questions about USP 797

Frequently Asked Questions: <797> Pharmaceutical Compounding—Sterile Preparations

Frequently Asked Questions: <797> Pharmaceutical Compounding—Sterile Preparations
Adapted from USP's FAQ on Compounding.
When was General Chapter <797> was last revised?
Is USP considering revisions to General Chapter <797>?
How can I obtain a copy of General Chapter <797>?
When will the final revision to General Chapter <797> be published?
How can I get status updates on the proposed revisions to General Chapter <797>?
Is <797> still enforceable?
How can I obtain a copy of the currently official General Chapter <797>?

For answers to these questions from USP itself, visit: http://www.usp.org/frequently-asked-questions/pharmaceutical-compounding-sterile-preparations

Additional Resources:

Follow USP.org:

USP.org on Twitter: https://twitter.com/uspharmacopeia
USP.org Blog: http://qualitymatters.usp.org/
USP.org on LinkedIn: https://www.linkedin.com/company/uspharmacopeia
USP.org on Facebook: https://www.facebook.com/USPharmacopeia

Follow USP800.guru:

USP800.guru on Twitter: https://www.twitter.com/usp800
USP800.org on Blogger: http://usp800.blogspot.com/
USP800.org on LinkedIn: https://www.linkedin.com/company/usp800-guru
USP800.org on Facebook:  https://www.facebook.com/USP800

Follow USP797.org:

USP797.org on Twitter: https://www.twitter.com/usp797
USP797.org on Blogger: http://usp797org.blogspot.com/
USP797.org on LinkedIn: https://www.linkedin.com/company/usp797-org-inc-
USP797.org on Facebook: https://www.facebook.com/usp797

Follow PharmacyDesign.org:

PharmacyDesign.org on Twitter: https://twitter.com/pharmacydesign
PharmacyDesign.org on Blogger: http://pharmacydesigns.blogspot.com/
PharmacyDesign.org on LinkedIn: https://www.linkedin.com/company/pharmacy-design
PharmacyDesign.org on Facebook: https://www.facebook.com/pharmacydesigns/

To reach USP797.org:

USP797.org
1483 York Avenue - #20602
New York, NY 10021
T: 800-974-3109
E: info@usp797.org
W: www.usp797.org

No comments: